BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10728444)

  • 1. Vascular endothelial growth factor and hypertrophic osteoarthropathy.
    Silveira LH; Martínez-Lavín M; Pineda C; Fonseca MC; Navarro C; Nava A
    Clin Exp Rheumatol; 2000; 18(1):57-62. PubMed ID: 10728444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of pulmonary adenocarcinoma associated with hypertrophic osteoarthropathy due to vascular endothelial growth factor.
    Abe Y; Kurita S; Ohkubo Y; Usui H; Hashizume T; Nakamura M; Ueyama Y; Fujino T
    Anticancer Res; 2002; 22(6B):3485-8. PubMed ID: 12552943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic osteoarthropathy.
    Martínez-Lavín M
    Best Pract Res Clin Rheumatol; 2020 Jun; 34(3):101507. PubMed ID: 32291203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic pulmonary osteoarthropathy associated with disease progression in renal cell carcinoma.
    Chen YC; Tiu CM; Bai LY; Liu JH
    J Chin Med Assoc; 2003 Jan; 66(1):63-6. PubMed ID: 12728977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature.
    Yao Q; Altman RD; Brahn E
    Semin Arthritis Rheum; 2009 Jun; 38(6):458-66. PubMed ID: 18760449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic osteoarthropathy: endothelium and platelet function.
    Silveri F; De Angelis R; Argentati F; Brecciaroli D; Muti S; Cervini C
    Clin Rheumatol; 1996 Sep; 15(5):435-9. PubMed ID: 8894355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating vascular endothelial growth factor concentrations in a case of pulmonary hypertrophic osteoarthropathy. Correlation with disease activity.
    Olán F; Portela M; Navarro C; Gaxiola M; Silveira LH; Ruiz V; Martínez-Lavín M
    J Rheumatol; 2004 Mar; 31(3):614-6. PubMed ID: 14994415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood intrathoracic Hodgkin lymphoma with hypertrophic pulmonary osteoarthropathy: a case report and review of the literature.
    Utine EG; Yalçin B; Karnak I; Kale G; Yalçin E; Doğru D; Kiper N; Akyüz C; Büyükpamukçu M
    Eur J Pediatr; 2008 Apr; 167(4):419-23. PubMed ID: 17605043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
    Tamura M; Ohta Y
    Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic osteoarthropathy: estrogens, prostaglandinE
    Brouwers A; Dingjan PG; Dujardin B; van Zoelen EJ; Lips P; Gooren LJ
    Clin Rheumatol; 2019 Jan; 38(1):211-222. PubMed ID: 29480386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "endothelium/platelet unit" in hypertrophic osteoarthropathy.
    Silveri F; Carlino G; Cervini C
    Clin Exp Rheumatol; 1992; 10 Suppl 7():61-6. PubMed ID: 1623677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma.
    Werther K; Christensen IJ; Nielsen HJ;
    Br J Cancer; 2002 Feb; 86(3):417-23. PubMed ID: 11875709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased angiogenic growth factor in cyanotic congenital heart disease.
    Himeno W; Akagi T; Furui J; Maeno Y; Ishii M; Kosai K; Murohara T; Kato H
    Pediatr Cardiol; 2003; 24(2):127-32. PubMed ID: 12360391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of hypertrophic osteoarthropathy.
    Martinez-Lavin M
    Clin Exp Rheumatol; 1992; 10 Suppl 7():49-50. PubMed ID: 1623674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum vascular endothelial growth factor is often elevated in disseminated cancer.
    Salven P; Mänpää H; Orpana A; Alitalo K; Joensuu H
    Clin Cancer Res; 1997 May; 3(5):647-51. PubMed ID: 9815732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P; Orpana A; Joensuu H
    Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer.
    Takigawa N; Segawa Y; Fujimoto N; Hotta K; Eguchi K
    Anticancer Res; 1998; 18(2B):1251-4. PubMed ID: 9615796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy.
    Eddahibi S; Humbert M; Sediame S; Chouaid C; Partovian C; Maître B; Teiger E; Rideau D; Simonneau G; Sitbon O; Adnot S
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1493-9. PubMed ID: 11029367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.